Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
MURA is expected to report earnings to rise 76.19% to -37 cents per share on March 31
Q4'25
Est.
$-0.37
Q3'25
Beat
by $0.09
Q2'25
Missed
by $1.68
Q1'25
Beat
by $0.05
Q4'24
Missed
by $0.02
The last earnings report on November 06 showed earnings per share of -20 cents, beating the estimate of -30 cents. With 74.42K shares outstanding, the current market capitalization sits at 36.21M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MURA showed earnings on November 06, 2025. You can read more about the earnings report here.